Cargando…
PITUITARY TUMORS-01 HYPERPROLACTINEMIA AS A CLINICAL MARKER OF INVASIVE PROLACTINOMAS
BACKGROUND: Prolactinomas can acquire an invasion feature and challenge the management. Many features of invasive pituitary adenomas have been investigated in the literature, from radiological, histopathological to molecular perspectives. Here, we have decided to focus on serum prolactin level and e...
Autores principales: | Gankpe, Gbetoho Fortune, Benzagmout, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616580/ http://dx.doi.org/10.1093/noajnl/vdad121.050 |
Ejemplares similares
-
PATIENT ADVOCACY-02 BRAIN TUMORS MATTER: HOW TO IMPROVE THE MANAGEMENT OF PATIENTS WITH BRAIN TUMORS AT THE CNHU HKM OF COTONOU IN BENIN?
por: Gankpe, Gbetoho Fortune
Publicado: (2023) -
PITUITARY TUMORS-02 EVOLUTION OF PITUITARY SURGERIES TO THE TRANS-SPHENOIDAL APPROACH IN A NIGERIAN TEACHING HOSPITAL: LEANING ON LOCAL TRANSFER OF SKILLS
por: Balogun, Simon, et al.
Publicado: (2023) -
FRI297 Hemoglobin Decline As A Signal For Hyperprolactinemia Onset Prior To Prolactinoma Diagnosis In Hypogonadal Men
por: Rudman, Yaron, et al.
Publicado: (2023) -
MON-LB080 Change of T2-Weighted Intensity of Prolactinoma as a Predictable Value for Relapse of Hyperprolactinemia after Cabergoline Withdrawal
por: Kim, Kyungwon, et al.
Publicado: (2019) -
SPINAL TUMORS-03 MALIGNANT PHYLLODES TUMOR OF THE BREAST WITH METASTASIS TO THE THORACIC SPINE: A CASE REPORT
por: Xavier, Rutayisire François, et al.
Publicado: (2023)